ClearPoint Neuro Surges Nearly 40% - Can The Stock Retest Its 52-week High?

Shares of ClearPoint Neuro Inc. (CLPT) are up nearly 40% at $17 in premarket trading on Wednesday.This global device, cell, and gene therapy-enabling company operates in two segments: (i) a providing medical devices for neurosurgical applications, and (ii) a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product is the ClearPoint system, designed to target and guide: (a) the insertion of deep brain stimulation electrodes, biopsy needles, and laser cath ...